Skip to main content

Dr. Ken Wan


Dr. Wan is a residency trained optometrist who specializes in ocular disease.

Dr. Ken Wan OD, FAAO, is a residency trained optometrist in ocular disease. He completed his Doctor of Optometry (OD) at the University of Waterloo School of Optometry and Vision Science followed by his Ocular Disease Residency at the Oklahoma Eye Institute through the Northeastern State University of Oklahoma. Prior to his return to Canada, he was a licensed optometrist in Oklahoma with certification in minor anterior segment and laser procedures that are currently outside the scope of practice for optometry in Canada.

Dr. Wan is passionate about the latest advancements in eye care and is a regularly attending member of the American Academy of Optometry (AAO).



Hon.B.Sc. in the physiology specialist program at the University of Toronto Saint George Campus.


O.D. at the University of Waterloo School of Optometry and Vision Science.


Ocular Disease Residency training at the Northeastern State University of Oklahoma.


2011 Canadian Optometric Education Trust Fund Award – University of Waterloo

2010 Science Graduate Experience Award – University of Waterloo

2010 Graduate Research Scholarship – University of Waterloo


Active member of Ontario Association of Optometrists

Active member of Canadian Association of Optometrists

Active member of American Academy of Optometry


Residency Seminar presentation:
Case report and literature review Northeastern State University

Paper submission to  Optometry and Vision Science:
Wan, K. (2016) “Early Giant Cell Arteritis Masquerading as 6th Nerve Palsy”

Poster presentation at the American Academy of Optometry:
Wan, K. (2016) “Deciphering the Evolving Symptomatology in Early Giant Cell Arteritis with Concurrent 6th Nerve Palsy” Anaheim, California

Contributed to paper in Gastroenterology:
Rowland, K.J., Trivedi, S., Wan, K., Kulkarni, R.N., Holzenberger, M., Robine, S. and Brubaker, P.L. (2011) “Selective loss of glucagon-like peptide-2-induced proliferative signaling in mice with conditional deletion of the intestinal epithelial insulin-like growth factor-1 receptor.” Toronto, Canada

Contributed to academic presentation:
Rowland, K.J., Lee D. and Wan, K. “Intestinal Epithelial Insulin-Like Growth Factor-1 Receptor Mediates Chronic Glucagon-Like Peptide-2-Induced Epithelial Proliferation and Associated Growth of the Crypt-Villus Unit” American gastroenterological association – Digestive Disease Week, May 10th 2011, Chicago, Illinois